Vanadium
SmallMolecule
T3DB_ID
T3D0198
描述
Vanadium is a steel-grey, corrosion-resistant metal, which exists in oxidation states ranging from -1 to +5. Metallic vanadium does not occur in nature, and the most common valence states are +3, +4, and +5. The pentavalent form (VO3-) predominates in extracellular body fluids whereas the quadrivalent form (VO+2) is the most common intracellular form. Because of its hardness and its ability to form alloys, vanadium (i.e., ferrovanadium) is a common component of hard steel alloys used in machines and tools. Although most foods contain low concentrations of vanadium (< 1 ng/g), food is the major source of exposure to vanadium for the general population. High air concentrations of vanadium occur in the occupation setting during boiler-cleaning operations as a result of the presence of vanadium oxides in the dust. The lungs absorb soluble vanadium compounds (V2O5) well, but the absorption of vanadium salts from the gastrointestinal tract is poor. The excretion of vanadium by the kidneys is rapid with a biological half-life of 20-40 hours in the urine. Physiologically, it exists as an ion in the body. Vanadium is probably an essential trace element, but a vanadium-deficiency disease has not been identified in humans. The estimated daily intake of the US population ranges from 10-60 micrograms V. Vanadyl sulfate is a common supplement used to enhance weight training in athletes at doses up to 60 mg/d. In vitro and animal studies indicate that vanadate and other vanadium compounds increase glucose transport activity and improve glucose metabolism. In general, the toxicity of vanadium compounds is low. Pentavalent compounds are the most toxic and the toxicity of vanadium compounds usually increases as the valence increases. Most of the toxic effects of vanadium compounds result from local irritation of the eyes and upper respiratory tract rather than systemic toxicity. The only clearly documented effect of exposure to vanadium dust is upper respiratory tract irritation characterized by rhinitis, wheezing, nasal hemorrhage, conjunctivitis, cough, sore throat, and chest pain. Case studies have described the onset of asthma after heavy exposure to vanadium compounds, but clinical studies to date have not detected an increased prevalence of asthma in workers exposed to vanadium. Vanadium is a trace element present in practically all cells in plants and animals. It exerts interesting actions in living systems. At pharmacological doses, vanadium compounds display relevant biological actions such as mimicking insulin and growth factors as well as having osteogenic activity. Some vanadium compounds also show antitumoral properties. The importance of vanadium in bone arises from the studies developed to establish the essentiality of this element in animals and humans. Bone tissue, where the element seems to play an important role, accumulates great amounts of vanadium. Among several metals, vanadium has emerged as an extremely potent agent with insulin-like properties. These insulin-like properties have been demonstrated in isolated cells, tissues, different animal models of type I and type II diabetes as well as a limited number of human subjects. Vanadium treatment has been found to improve abnormalities of carbohydrate and lipid metabolism and of gene expression in rodent models of diabetes. In isolated cells, it enhances glucose transport, glycogen and lipid synthesis, and inhibits gluconeogenesis and lipolysis. The molecular mechanism responsible for the insulin-like effects of vanadium compounds have been shown to involve the activation of several key components of insulin-signaling pathways that include the mitogen-activated-protein kinases (MAPKs) extracellular signal-regulated kinase 1/2 (ERK1/2) and p38MAPK, and phosphatidylinositol 3-kinase (PI3-K)/protein kinase B (PKB). (A7727, A7728, A7729)
类别
"Food Toxin", "Natural Toxin"
同义词
"V", "Vanadate", "Vanadium ion", "Vanadium(II)", "Vanadium(III)", "Vanadium(IV)", "Vanadium(V)"
CAS登记号
7440-62-2
化学式
V
平均分子量
50.9399
单同位素质量
50.942317935
IUPAC 名称
vanadium(3+) ion
传统名称
vanadium(3+) ion
简化分子线性输入规范
[V+3]
InChI 标识符
InChI=1S/V/q+3
InChIKey=KOKKJWHERHSKEB-UHFFFAOYSA-N
化合物类型
Inorganic compounds
大分类
Homogeneous metal compounds
类型
Homogeneous transition metal compounds
子类
直接大类
Homogeneous transition metal compounds
另外分类
""
取代基
"Homogeneous transition metal"
分子框架
外部描述符
"monoatomic trication", "vanadium cation"
地位
Detected and Not Quantified
起源
Exogenous
蜂窝位置
"Cytoplasm", "Extracellular"
生物流体位置
组织位置
途径
状态
Solid
外貌
Grey metallic solid.
熔点/沸点/溶解度
1910°C/3380°C (6116°F)/
日志P
暴露途径
Oral (L837) ; inhalation (L837) ; dermal (L837)
毒性机制
Vanadium damages alveolar macrophages by decreasing the macrophage membrane integrity, thus impairing the cell's phagocytotic ability and viability. The pentavalent form of vanadium, vanadate, is a potent inhibitor of the Ca+-ATPase and Na+,K+-ATPase of plasma membranes, which decreases intracellular ATP concentration. Vanadium is also believed to induce the production of reactive oxygen species. This may damage DNA and also cause oxidative stress, which can damage the reproductive system. Vanadium also inhibits protein tyrosine phosphatases, producing insulin-like effects. (L837, A247, A248, A249, A250, A251)
代谢
Vanadium is absorbed mainly via inhalation, though small amounts can be absorbed through the skin and gastrointestional tract. It is rapidly distributed in the plasma, mainly to the kidney, liver, lungs, heart, bone, where it tends to accumulate. With the help of cytochrome P-450 enzymes, it can interconvert between its two oxidation states, vanadyl (V+4) and vanadate (V+5). Both states of vanadium can reversibly bind to transferrin protein in the blood and then be taken up into erythrocytes. Vanadium is excreted mainly in the urine. (L837)
毒性值
致死剂量
致癌性
No indication of carcinogenicity to humans (not listed by IARC).
用途/来源
Vanadium is mainly used to produce specialty steel alloys such as high speed tool steels. It is also mixed with iron to make important parts for aircraft engines, and small amounts are used in making rubber, plastics, ceramics, and other chemicals. (L837, L838)
最低风险等级
Acute Inhalation: 0.0002 mg/m3 (L134) Intermediate Oral: 0.003 mg/kg/day (L134)
健康影响
Breathing high levels of vanadium affects the lungs, throat, and eyes. Ingestion of vanadium may cause kidney and liver damage, birth defects, or death. (L837)
症状
Inhalation of vanadium causes lung irritation, coughing, wheezing, chest pain, runny nose, and a sore throat. (L837)
治疗
药库 ID
HMDB_ID
HMDB02503
PubChem 化合物 ID
23990
维基百科链接
http://en.wikipedia.org/wiki/Vanadium
创建于
2009-03-06 18:58:16 UTC
更新于
2014-12-24 20:21:19 UTC
目标
毒素T3DB ID毒素名称目标名称
T3D0198 Vanadium Tyrosine-protein phosphatase non-receptor type 3
T3D0198 Vanadium Tyrosine-protein phosphatase non-receptor type 9
T3D0198 Vanadium Tyrosine-protein phosphatase non-receptor type 7
T3D0198 Vanadium Tyrosine-protein phosphatase non-receptor type 6
T3D0198 Vanadium Tyrosine-protein phosphatase non-receptor type 5
T3D0198 Vanadium Tyrosine-protein phosphatase non-receptor type 4
T3D0198 Vanadium Tyrosine-protein phosphatase non-receptor type 23
T3D0198 Vanadium Tyrosine-protein phosphatase non-receptor type 22
T3D0198 Vanadium Tyrosine-protein phosphatase non-receptor type 21
T3D0198 Vanadium Tyrosine-protein phosphatase non-receptor type 20
T3D0198 Vanadium Tyrosine-protein phosphatase non-receptor type 2
T3D0198 Vanadium Tyrosine-protein phosphatase non-receptor type 18
T3D0198 Vanadium Tyrosine-protein phosphatase non-receptor type 14
T3D0198 Vanadium Tyrosine-protein phosphatase non-receptor type 13
T3D0198 Vanadium Tyrosine-protein phosphatase non-receptor type 12
T3D0198 Vanadium Tyrosine-protein phosphatase non-receptor type 11
T3D0198 Vanadium Tyrosine-protein phosphatase non-receptor type 1
T3D0198 Vanadium Receptor-type tyrosine-protein phosphatase-like N
T3D0198 Vanadium Receptor-type tyrosine-protein phosphatase zeta
T3D0198 Vanadium Receptor-type tyrosine-protein phosphatase U
T3D0198 Vanadium Receptor-type tyrosine-protein phosphatase T
T3D0198 Vanadium Receptor-type tyrosine-protein phosphatase S
T3D0198 Vanadium Receptor-type tyrosine-protein phosphatase R
T3D0198 Vanadium Receptor-type tyrosine-protein phosphatase O
T3D0198 Vanadium Receptor-type tyrosine-protein phosphatase N2
T3D0198 Vanadium Receptor-type tyrosine-protein phosphatase mu
T3D0198 Vanadium Receptor-type tyrosine-protein phosphatase kappa
T3D0198 Vanadium Receptor-type tyrosine-protein phosphatase H
T3D0198 Vanadium Receptor-type tyrosine-protein phosphatase gamma
T3D0198 Vanadium Receptor-type tyrosine-protein phosphatase F
T3D0198 Vanadium Receptor-type tyrosine-protein phosphatase eta
T3D0198 Vanadium Receptor-type tyrosine-protein phosphatase epsilon
T3D0198 Vanadium Receptor-type tyrosine-protein phosphatase delta
T3D0198 Vanadium Receptor-type tyrosine-protein phosphatase beta
T3D0198 Vanadium Receptor-type tyrosine-protein phosphatase alpha
T3D0198 Vanadium Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1
T3D0198 Vanadium Protein tyrosine phosphatase type IVA 3
T3D0198 Vanadium Protein tyrosine phosphatase type IVA 2
T3D0198 Vanadium Protein tyrosine phosphatase type IVA 1
T3D0198 Vanadium Sodium/potassium-transporting ATPase subunit beta-3
T3D0198 Vanadium Sodium/potassium-transporting ATPase subunit beta-2
T3D0198 Vanadium Sodium/potassium-transporting ATPase subunit beta-1
T3D0198 Vanadium Sodium/potassium-transporting ATPase subunit alpha-4
T3D0198 Vanadium Sodium/potassium-transporting ATPase subunit alpha-3
T3D0198 Vanadium Sodium/potassium-transporting ATPase subunit alpha-2
T3D0198 Vanadium Sodium/potassium-transporting ATPase subunit alpha-1
T3D0198 Vanadium Sodium/potassium-transporting ATPase subunit gamma
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3